MeSH term
Frequency | Condition_Probility | Humans | 61 | 0.0 |
Animals | 35 | 0.0 |
COS Cells | 9 | 0.0 |
Hela Cells | 15 | 0.0 |
Protein Binding | 9 | 0.0 |
Receptors, Cytoplasmic and Nuclear/chemistry/*metabolism | 3 | 27.0 |
Research Support, Non-U.S. Gov't | 38 | 0.0 |
Carrier Proteins/*metabolism | 2 | 0.0 |
Transfection | 18 | 0.0 |
Dimerization | 5 | 0.0 |
Ligands | 8 | 0.0 |
Rats | 6 | 0.0 |
Retinoid X Receptors | 5 | 1.0 |
Transcription Factors/genetics/metabolism | 4 | 0.0 |
Tumor Cells, Cultured | 12 | 0.0 |
Cells, Cultured | 4 | 0.0 |
DNA/metabolism | 4 | 0.0 |
Glutathione Transferase/metabolism | 3 | 0.0 |
Male | 14 | 0.0 |
Mice | 16 | 0.0 |
Receptors, Cytoplasmic and Nuclear/genetics/*metabolism | 6 | 12.0 |
Receptors, Retinoic Acid/metabolism | 2 | 2.0 |
Research Support, U.S. Gov't, P.H.S. | 34 | 0.0 |
Trans-Activation (Genetics)/drug effects | 2 | 0.0 |
Cell Line | 13 | 0.0 |
Models, Biological | 3 | 0.0 |
Protein-Arginine N-Methyltransferase/genetics/metabolism | 2 | 100.0 |
Receptors, Cytoplasmic and Nuclear/*metabolism | 4 | 2.0 |
Trans-Activation (Genetics) | 6 | 0.0 |
Gene Expression | 2 | 0.0 |
Gene Targeting | 2 | 0.0 |
Mice, Knockout | 2 | 0.0 |
Transcription Factors/genetics/*physiology | 2 | 1.0 |
Binding Sites | 12 | 0.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
Nuclear Proteins/genetics/*metabolism | 5 | 1.0 |
Proteins/metabolism | 2 | 0.0 |
*Signal Transduction | 2 | 0.0 |
Transcription Factors/*metabolism | 7 | 0.0 |
Cercopithecus aethiops | 3 | 0.0 |
DNA-Binding Proteins/genetics/metabolism | 3 | 0.0 |
Genes, Reporter | 5 | 0.0 |
Nuclear Proteins/metabolism | 5 | 0.0 |
Phosphoproteins/genetics/*metabolism | 3 | 1.0 |
Protein Binding/physiology | 2 | 0.0 |
Protein Structure, Tertiary/physiology | 2 | 1.0 |
Recombinant Fusion Proteins/genetics/metabolism | 3 | 0.0 |
Repressor Proteins/genetics/metabolism | 2 | 2.0 |
Sequence Deletion | 3 | 0.0 |
Trans-Activators/metabolism | 5 | 0.0 |
Transcription Factors/genetics/*metabolism | 10 | 1.0 |
Two-Hybrid System Techniques | 5 | 0.0 |
Breast Neoplasms/genetics/metabolism | 2 | 4.0 |
Estrogen Receptor alpha | 5 | 2.0 |
Protein Structure, Tertiary | 11 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 10 | 0.0 |
Trans-Activation (Genetics)/physiology | 2 | 2.0 |
Luciferases/metabolism | 2 | 0.0 |
Mammary Tumor Virus, Mouse/genetics | 2 | 5.0 |
Models, Genetic | 3 | 0.0 |
Plasmids/metabolism | 2 | 0.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
Transcription Factors/metabolism | 5 | 0.0 |
Transcription, Genetic | 7 | 0.0 |
Receptors, Glucocorticoid/metabolism | 2 | 3.0 |
Receptors, Thyroid Hormone/metabolism | 3 | 8.0 |
Amino Acid Sequence | 13 | 0.0 |
Gene Expression Regulation, Developmental | 2 | 0.0 |
Molecular Sequence Data | 10 | 0.0 |
Mutation/genetics | 2 | 0.0 |
Phenotype | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Androgen Antagonists/pharmacology | 2 | 5.0 |
Anilides/pharmacology | 2 | 7.0 |
Carrier Proteins/metabolism | 3 | 0.0 |
Comparative Study | 5 | 0.0 |
Promoter Regions (Genetics)/*genetics | 2 | 0.0 |
Estradiol/pharmacology | 2 | 0.0 |
Mutation | 3 | 0.0 |
Precipitin Tests | 2 | 0.0 |
Recombinant Fusion Proteins/metabolism | 7 | 0.0 |
Time Factors | 2 | 0.0 |
*Trans-Activation (Genetics) | 7 | 0.0 |
Cell Line, Tumor | 5 | 0.0 |
Promoter Regions (Genetics) | 7 | 0.0 |
Female | 7 | 0.0 |
Immunoblotting | 2 | 0.0 |
Protein Conformation | 3 | 0.0 |
Phosphorylation | 2 | 0.0 |
Receptors, Steroid/*metabolism | 2 | 3.0 |
Base Sequence | 3 | 0.0 |
Drug Synergism | 2 | 0.0 |
Response Elements | 3 | 1.0 |
Signal Transduction | 7 | 0.0 |
Structure-Activity Relationship | 3 | 0.0 |
Conserved Sequence | 2 | 0.0 |
Peptide Fragments/chemistry/genetics/metabolism | 2 | 2.0 |
Cloning, Molecular | 2 | 0.0 |
Blotting, Western | 3 | 0.0 |
Carrier Proteins/genetics/*metabolism | 3 | 0.0 |
DNA Primers | 2 | 0.0 |
*Gene Expression Regulation | 2 | 0.0 |
Nerve Tissue Proteins/genetics/*metabolism | 2 | 1.0 |
Receptors, AMPA/genetics/*metabolism | 2 | 66.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Amino Acid Substitution | 2 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Protein Structure, Secondary | 2 | 0.0 |
Recombinant Fusion Proteins/chemistry/metabolism | 3 | 1.0 |
*Transcription, Genetic | 6 | 0.0 |
Amino Acid Motifs | 2 | 0.0 |
Macromolecular Substances | 3 | 0.0 |
Saccharomyces cerevisiae/genetics/metabolism | 2 | 1.0 |
*Saccharomyces cerevisiae Proteins | 5 | 0.0 |
Gene Expression Regulation | 4 | 0.0 |
Receptors, Estrogen/*metabolism | 2 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Receptors, Cytoplasmic and Nuclear/*genetics | 2 | 2.0 |
Transcription Factors/*genetics/metabolism | 2 | 0.0 |
*DNA-Binding Proteins | 2 | 0.0 |
Transcription Factors/chemistry/*metabolism | 3 | 2.0 |
Binding, Competitive | 2 | 0.0 |
Nuclear Proteins/genetics/metabolism | 2 | 1.0 |
Recombinant Proteins/genetics/metabolism | 2 | 0.0 |
Trans-Activators/genetics/*metabolism | 4 | 1.0 |
*Mutation | 2 | 0.0 |
Nuclear Proteins/*metabolism | 2 | 0.0 |
Models, Molecular | 2 | 0.0 |
Protein-Arginine N-Methyltransferase/metabolism | 2 | 40.0 |
Binding Sites/genetics | 2 | 0.0 |
Trans-Activation (Genetics)/*genetics | 2 | 2.0 |
Risk Factors | 2 | 0.0 |
Repressor Proteins/*physiology | 2 | 1.0 |
Transcription Factors/chemistry/*physiology | 2 | 5.0 |
Adult | 2 | 0.0 |
Middle Aged | 2 | 0.0 |
Receptors, Androgen/genetics/*metabolism | 3 | 6.0 |
